Difference between revisions of "Magnani L, et al. Proc. Natl Acad. Sci. USA (2013) cited as Ref 613 in DOI: 10.1038/s41392-020-0110-5 (Q9876)"
Jump to navigation
Jump to search
(Created claim: DOI Identifier (P138): 10.1073/pnas.1219992110, #quickstatements; #temporary_batch_1590000649558) |
(Created claim: Page(s) (P105): E1490-E1499, #quickstatements; #temporary_batch_1590074839150) |
||||||||||||||
(5 intermediate revisions by the same user not shown) | |||||||||||||||
Property / PubMed ID | |||||||||||||||
+ | |||||||||||||||
Property / PubMed ID: 23576735 / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / Publication Date | |||||||||||||||
+ | 2013
| ||||||||||||||
Property / Publication Date: 2013 / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / Published In Name String | |||||||||||||||
+ | Proc. Natl Acad. Sci. USA | ||||||||||||||
Property / Published In Name String: Proc. Natl Acad. Sci. USA / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / Volume | |||||||||||||||
+ | 110 | ||||||||||||||
Property / Volume: 110 / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / title | |||||||||||||||
+ | Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer (English) | ||||||||||||||
Property / title: Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer (English) / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / Page(s) | |||||||||||||||
+ | E1490-E1499 | ||||||||||||||
Property / Page(s): E1490-E1499 / rank | |||||||||||||||
+ | Normal rank |
Latest revision as of 15:47, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language | Label | Description | Also known as |
---|---|---|---|
English |
Magnani L, et al. Proc. Natl Acad. Sci. USA (2013) cited as Ref 613 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Magnani L
0 references
2013
0 references
Proc. Natl Acad. Sci. USA
0 references
110
0 references
Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer (English)
0 references
E1490-E1499
0 references